This study is designed to determine whether subjects who were responders to cNEP during an overnight sleep lab titration in a previous clinical trial, Study SOM-012, will maintain a response throughout the night for up to two weeks in a home setting. It will also be determined whether two weeks of home use of cNEP is associated with any adverse events.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
continuous negative external pressure will be applied to the anterior neck at night
California Center for Sleep Disorders
Alameda, California, United States
Reduction in baseline apnea hypopnea index from baseline
Reduction in apnea hypopnea index (AHI) from the baseline value of \>50% and also \<15/hr
Time frame: End of Week 2 of home use
Collection of adverse events
Collection of adverse events
Time frame: two week study period
Apnea hypopnea index, as measured by home sleep testing
Comparison of AHI from home sleep testing in this study to those of the polysomnogram (PSG) in SOM-012
Time frame: two weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.